(ASMI) is undertaking a
review of its Code of Practice and
as part of that review is seeking
suggestions for potential revisions
to the Code.
Any members with suggestions
for how the ASMI Code of Practice
might be revised should complete
the form and return it to steve@asmi.com.au by 12 Jul 2016.
For reference, the current ASMI
Code of Practice is available on the
ASMI website at www.asmi.com.au.
In addition, members wishing
to discuss the matter can contact
Steve Scarff on 02 9922 5111.The above article was sent to subscribers in Pharmacy Daily's issue from 09 Jun 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Jun 16
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FROM 01 May, pharmacists will be able to dispense Verzenio (abemaciclib) through the PBS to treat Australian patients with an invasive form of early breast cancer that is at high risk of recurring after initial treatment.
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.